RET and primary hyperparathyroidism: MEN2A, the predominant phenotype of MEN2, is caused by germline mutations in the RET proto-oncogene that predispose carriers to an increased risk to development of medullary thyroid cancer (MTC), pheochromocytoma, and primary hyperparathyroidism to different degrees (2).